RSSCurrent Issue

Editorial Message and Issue Highlights–Vol. 16, No. 3–4, March-April 2019

Editorial Message and Issue Highlights–Vol. 16, No. 3–4, March-April 2019

| March 1, 2019

Dear Colleagues: Welcome to the March–April 2019 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a Psychotherapy Rounds submission titled, “Addiction Disorder Considerations in Patients Seeking Psychotherapy,” by Stubbs and Merrill. It is not uncommon for a patient with a psychiatric disorder to present with a comorbid substance use disorder, and […]

Continue Reading

The Pathophysiology of Marijuana-induced Encephalopathy and Possible Epilepsy after Ingestion in Children: A Case Series

The Pathophysiology of Marijuana-induced Encephalopathy and Possible Epilepsy after Ingestion in Children: A Case Series

| March 1, 2019

by Alister Carvalho, MBBS, and Tracy Evans-Gilbert, DM, MPH, CTropMed® Drs. Carvalho and Evans-Gilbert are with the Department of Pediatrics at the Cornwall Regional Hospital in Montego Bay, Jamaica. Dr. Evans-Gilbert is also with the University of the West Indies, Western Campus, in Montego Bay, Jamaica. Funding: No funding was provided. Disclosures: The authors have […]

Continue Reading

Panic Attacks in Hyperaldosteronism

Panic Attacks in Hyperaldosteronism

| March 1, 2019

by Tiffany Y. Lin, MD; Rebecca M. Hedrick, MD; and Waguih William IsHak, MD, FAPA Drs. Lin and IsHak are with the David Geffen School of Medicine at University of California–Los Angeles in Los Angeles, California. Drs. Hedrick and IsHak are with Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, […]

Continue Reading

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

| March 1, 2019

by Laetitia Pouzol, MSc, PharmD; Luca Piali, PhD; Claude CA Bernard, PhD; Marianne M. Martinic, PhD; Beat Steiner, PhD; and Martine Clozel, MD Drs. Pouzol and Clozel were with Actelion Pharmaceuticals Ltd. in Allschwil, Switzerland, at the time of this research, and are presently with Idorsia Pharmaceuticals Ltd. in Allschwil, Switzerland. Dr. Piali was with […]

Continue Reading

The Top Three Things to Know about the Top Three Risk Management Issues

The Top Three Things to Know about the Top Three Risk Management Issues

| March 1, 2019

by Charles D. Cash, JD, LLM Mr. Cash is Assistant Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee of PRMS Inc., a risk management consulting company for healthcare providers. Innov Clin Neurosci. 2019;16(3–4):31–32 This ongoing column is dedicated […]

Continue Reading